Orchestra BioMed Holdings OBIO
NASDAQ OBIO
$5.08 +0.34 (+7.17%)
At close: Sep 4, 2026 · 4:00 PM EDT

Orchestra BioMed Holdings (OBIO) Interest & Investment Income (2023 - 2026)

Analysis

Orchestra BioMed Holdings (OBIO) Interest & Investment Income (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 35.58 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 5.13 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 10.98 Mn
10 Orchestra BioMed Holdings 322.25 Mn 127.72 Mn 63,000.00 -1.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.77 Mn
Mar 31, 2026 -821,000.00
Dec 31, 2025 -763,000.00
Sep 30, 2025 -515,000.00
Jun 30, 2025 -36,000.00
Mar 31, 2025 166,000.00
Dec 31, 2024 522,000.00
Sep 30, 2024 916,000.00
Jun 30, 2024 902,000.00
Mar 31, 2024 1.02 Mn
Dec 31, 2023 1.11 Mn
Sep 30, 2023 915,000.00